Journal
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY
Volume 10, Issue 10, Pages 568-569Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrgastro.2013.165
Keywords
-
Categories
Ask authors/readers for more resources
A large proportion of hepatitis C in the developed world occurs in injection drug users. Treatment uptake in this population is low, despite the rising burden of HCV-related liver disease. Multiple barriers preclude the optimal care of hepatitis C in injection drug users, including low medication adherence and HCV re-infection.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available